pefloxacin has been researched along with Paratyphoid Fever in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaji, V; Dahiya, S; Das, BK; Kapil, A; Kumari, B; Sharma, P; Sood, S | 1 |
| Balloul, H; Perronne, C; Thiollier, S; Vachon, F | 1 |
| Benbachir, M; el Filali, KM; el Mdaghri, N; Hajji, M; Himmich, H | 1 |
| Akalin, HE; Akova, M; Gür, D; Hayran, M; Tuncer, S; Unal, S; Uzun, O | 1 |
2 trial(s) available for pefloxacin and Paratyphoid Fever
| Article | Year |
|---|---|
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Topics: Adult; Drug Combinations; Female; Humans; Male; Norfloxacin; Paratyphoid Fever; Pefloxacin; Prospective Studies; Random Allocation; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1988 |
Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.
Topics: 4-Quinolones; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Paratyphoid Fever; Pefloxacin; Prospective Studies; Quinolones; Salmonella paratyphi B; Treatment Outcome; Typhoid Fever | 1996 |
2 other study(ies) available for pefloxacin and Paratyphoid Fever
| Article | Year |
|---|---|
Pefloxacin as a surrogate marker for quinolone susceptibility in
Topics: Anti-Bacterial Agents; Biomarkers; Drug Resistance, Bacterial; Humans; Mutation; Paratyphoid Fever; Pefloxacin; Salmonella enterica; Salmonella paratyphi A | 2017 |
[Relapse of parathyroid fever after ten days' treatment with pefloxacin].
Topics: Adult; Humans; Male; Paratyphoid Fever; Pefloxacin; Recurrence; Thiamphenicol | 1991 |